BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244,820 | -43.8% | 6,487 | -32.1% | 0.01% | -40.0% |
| Q2 2023 | $435,326 | +48.8% | 9,555 | +32.5% | 0.01% | +42.9% |
| Q1 2023 | $292,479 | +9.1% | 7,211 | +37.1% | 0.01% | -12.5% |
| Q4 2022 | $268,153 | -23.4% | 5,261 | -19.1% | 0.01% | -33.3% |
| Q3 2022 | $350,000 | -2.5% | 6,501 | +16.5% | 0.01% | -7.7% |
| Q2 2022 | $359,000 | -21.8% | 5,582 | -5.6% | 0.01% | -7.1% |
| Q1 2022 | $459,000 | -8.6% | 5,914 | +1.1% | 0.01% | -6.7% |
| Q4 2021 | $502,000 | +8.7% | 5,848 | +1.9% | 0.02% | -6.2% |
| Q3 2021 | $462,000 | -1.3% | 5,738 | -1.3% | 0.02% | 0.0% |
| Q2 2021 | $468,000 | -2.5% | 5,813 | +2.2% | 0.02% | -11.1% |
| Q1 2021 | $480,000 | -7.7% | 5,686 | -12.2% | 0.02% | -14.3% |
| Q4 2020 | $520,000 | -10.8% | 6,473 | -10.8% | 0.02% | -19.2% |
| Q3 2020 | $583,000 | -11.3% | 7,255 | -4.9% | 0.03% | -16.1% |
| Q2 2020 | $657,000 | +6.3% | 7,629 | +0.3% | 0.03% | -13.9% |
| Q1 2020 | $618,000 | +4.2% | 7,603 | +7.2% | 0.04% | +33.3% |
| Q4 2019 | $593,000 | -5.1% | 7,094 | -0.7% | 0.03% | -6.9% |
| Q3 2019 | $625,000 | +10.6% | 7,147 | +3.5% | 0.03% | +7.4% |
| Q2 2019 | $565,000 | +8.9% | 6,905 | +8.2% | 0.03% | 0.0% |
| Q1 2019 | $519,000 | +21.0% | 6,381 | -2.2% | 0.03% | +8.0% |
| Q4 2018 | $429,000 | -19.5% | 6,526 | -5.6% | 0.02% | -10.7% |
| Q3 2018 | $533,000 | +2.5% | 6,914 | -1.8% | 0.03% | -3.4% |
| Q2 2018 | $520,000 | +136.4% | 7,044 | +107.8% | 0.03% | +141.7% |
| Q1 2018 | $220,000 | -10.2% | 3,390 | -10.5% | 0.01% | -7.7% |
| Q4 2017 | $245,000 | +3.8% | 3,789 | +0.3% | 0.01% | 0.0% |
| Q3 2017 | $236,000 | -14.8% | 3,777 | -15.9% | 0.01% | -35.0% |
| Q2 2017 | $277,000 | – | 4,493 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |